HOOKIPA Pharma Inc.

NASDAQ: HOOK · Real-Time Price · USD
0.83
-0.01 (-1.19%)
At close: Aug 15, 2025, 1:55 PM
0.83
0.00%
After-hours: Aug 15, 2025, 01:55 PM EDT

HOOKIPA Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2M 1.35M 4.7M 1.29M 36.6M 7.41M 6.87M 2.68M 3.18M 7.83M 2.23M 2.75M 1.45M 3.9M 3.87M 5.38M 5.3M
Cost of Revenue
n/a 699K n/a n/a n/a 1.28M 487K 866K 921K 904K 760K 860K 1.08M 1.23M 20.7M 19.57M 20.16M
Gross Profit
2M 655K 4.7M 1.29M 36.6M 6.13M 6.38M 1.81M 2.25M 6.92M 1.47M 1.89M 367K 2.67M -16.82M -14.19M -14.86M
Operating Income
-17.87M -21.46M -18.64M -22.46M 11.11M -18.13M -22.67M -21.47M -22.66M -13.59M -20.99M -18.43M -20.15M -22.05M -21.17M -19.29M -19.17M
Interest Income
236K 488K 809K 1.07M 1.33M 1.24M 1.57M 1.31M 1.17M 909K 535K 182K 7K 6K 7K 7K 7K
Pretax Income
-15.43M -25.06M -13.84M -19.09M 14.38M -24.65M -19.07M -18.02M -19.68M -12.31M -18.28M -16.36M -17.97M -21.23M -20.04M -17.15M -17.24M
Net Income
-15.43M -24.95M -13.84M -19.09M 14.38M -24.82M -19.07M -18.02M -19.68M -12.31M -18.28M -16.36M -17.97M -21.23M -20.04M -17.15M -17.24M
Selling & General & Admin
6.89M 5.49M 6.73M 3.94M 4.06M 3.1M 4.91M 4.45M 4.9M 3.82M 4.94M 5.03M 4.97M 3.52M 4.34M 5.09M 4.31M
Research & Development
12.86M 13.03M 15.56M 19.75M 20.17M 21.16M 24.63M 19.71M 20.93M 17.59M 18.29M 16.15M 16.62M 22.42M 20.7M 19.57M 20.16M
Other Expenses
133K 4.29M 1.05M 54K 1.27M n/a -833K 25K -220K -1.28M -2.08M -1.96M -1.89M -1.5M -1.13M -158K -58K
Operating Expenses
19.88M 22.81M 23.35M 23.75M 25.49M 24.26M 29.54M 21.93M 25.83M 21.42M 21.14M 19.21M 19.7M 25.94M 22.55M 22.16M 22.27M
Interest Expense
n/a n/a n/a n/a 2K 49K 49K 97K 122K 108K 105K 231K 243K 227K 234K 218K 219K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -1.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
19.88M 18.52M 23.35M 23.75M 25.49M 25.54M 29.54M 21.93M 25.83M 21.42M 21.14M 19.21M 19.7M 25.94M 22.55M 22.16M 22.27M
Income Tax Expense
n/a -106K n/a n/a n/a 164K n/a 122K 205K 229K n/a 1K n/a -2K 1K 60K 161K
Shares Outstanding (Basic)
12.54M 12.05M 12.54M 12.54M 13.08M 11.28M 11.04M 8.26M 7.22M 7.24M 7.22M 7.22M 4.5M 3.27M 3.29M 3.28M 3.28M
Shares Outstanding (Diluted)
12.54M 12.05M 12.54M 12.54M 12.6M 11.28M 11.04M 8.27M 7.22M 7.24M 7.22M 7.22M 4.5M 3.27M 3.29M 3.28M 3.28M
EPS (Basic)
-1.23 -1.99 -1.1 -1.52 1.15 -2.2 -1.73 -2.18 -2.73 -1.7 -2.53 -2.27 -3.99 -6.5 -6.1 -5.23 -5.26
EPS (Diluted)
-1.23 -1.99 -1.1 -1.52 1.10 -2.2 -1.73 -2.18 -2.73 -1.7 -2.53 -2.27 -3.99 -6.5 -6.1 -5.23 -5.26
EBITDA
-15.04M -24.36M -13.14M -18.38M 15.03M -23.33M -18.53M -17.05M -18.43M -11.07M -17.41M -15.26M -16.65M -19.78M -18.71M -15.72M -15.92M
EBIT
-15.43M -25.06M -13.84M -19.09M 14.38M -24.61M -19.02M -17.92M -19.35M -11.97M -18.18M -16.12M -17.73M -21.01M -19.8M -16.93M -17.02M
Depreciation & Amortization
389K 699K 700K 714K 640K 1.28M 487K 866K 921K 904K 760K 860K 1.08M 1.23M 1.09M 1.22M 1.1M